Kellen Scott 4
4 · DiaMedica Therapeutics Inc. · Filed Jun 2, 2022
Insider Transaction Report
Form 4
Kellen Scott
CFO & Secretary
Transactions
- Award
Stock Option (right to buy)
2022-06-01+60,000→ 60,000 totalExercise: $2.45Exp: 2032-05-31→ Common Shares (60,000 underlying)
Holdings
- 22,290
Voting Common Shares, no par value per share
Footnotes (1)
- [F1]Vests with respect to 25% of the underlying common shares on June 1, 2023 and with respect to the remaining 75% of the underlying common shares in 36 as nearly equal as possible monthly installments commencing on July 1, 2023.